How do bioidentical hormone replacement pellets compare to standard estrogen and progesterone pills regarding cardiovascular risks in early menopause?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
How do bioidentical hormone replacement pellets compare to standard estrogen and progesterone pills regarding cardiovascular risks in early menopause?
2 real searches · 1 real-search pass
2025 menopause hormone therapy cardiovascular risk oral estrogen transdermal estradiol micronized progesterone pellets guideline FDA compounded bioidenticalGoogle ↗
OBSERVED
NAMS menopause hormone therapy position statement route administration cardiovascular risk compounded pellets FDA approved bioidentical hormonesGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
2025 menopause hormone therapy cardiovascular risk oral estrogen transdermal estradiol micronized progesterone pellets guideline FDA compounded bioidentical Google ↗
NAMS menopause hormone therapy position statement route administration cardiovascular risk compounded pellets FDA approved bioidentical hormones Google ↗
- Compounded Bioidentical Menopausal Hormone Therapy · acog.org
- Full article: International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause · doi.org
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- Compounded Bioidentical Hormone Therapy · endocrine.org
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR MENOPAUSE · healthquality.va.gov
- Menopause · fda.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2025 menopause hormone therapy cardiovascular risk oral estrogen transdermal estradiol micronized progesterone pellets guideline FDA compounded bioidentical OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
NAMS menopause hormone therapy position statement route administration cardiovascular risk compounded pellets FDA approved bioidentical hormones OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |